Abbvie Clinical Trials for Myelofibrosis and Acute Myeloid Leukemia

• June 30, 2022
• Clinical Trials

Myelofibrosis

1. Transform-1 (M16-191)
   1. Phase 3 Study Of Navitoclax In Combination With Ruxolitinib Versus Ruxolitinib In Subjects With Myelofibrosis
   2. FL sites:
      1. Lynn Cancer Institute in Boca
      2. FCS South

• FCS East

1. FCS North

1. gov: https://www.clinicaltrials.gov/ct2/show/NCT04472598

Acute Myeloid Leukemia

1. Viale-T (M19-063)
   1. Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine After Allogeneic Stem Cell Transplantation in Subjects With AML
   2. FL sites:
      1. AdventHealth Orlando
      2. Mayo Clinic Jacksonville (not active)
   3. gov: https://clinicaltrials.gov/ct2/show/NCT04161885
2. Viale-M (M19-708)
   1. Phase 3 Study of Venetoclax and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy for Patients With AML in First Remission After Conventional Chemotherapy
   2. FL sites:
      1. Baptist MD Anderson Cancer Center in Jacksonville (not active)
   3. gov: https://clinicaltrials.gov/ct2/show/NCT04102020